Single dose vaccination with TNX-801 protects animals from a lethal challenge with monkeypox, the causative agent of mpox TNX ...

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw its stock rise 2% after unveiling new preclinical findings for its ...

Tonix Pharmaceuticals (TNXP) stock gains as the company posts peer-reviewed data for pain drug TNX-102 and new data for mpox ...

Tonix Pharmaceuticals TNXP reported positive Phase 3 study results for its non-opioid painkiller in late December. The drug lowered the characteristic widespread pain in fibromyalgia reported by ...

CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of ...

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are soaring Monday after the World Health Organization (WHO) declared monkeypox a public health emergency of global concern.

On Monday, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) and Bilthoven Biologicals collaborated to advance TNX-801, Tonix’s mpox vaccine candidate. Bilthoven Biologicals is part of the world ...

The Tonix Pharmaceuticals lost $50 million last year, and there's no telling when the bleeding is going to stop because we still don't know if TNX-1800 has a shot at earning FDA approval.

New Jersey-headquartered clinical-stage biotech firm Tonix Pharmaceuticals (NASDAQ:TNXP) is a love-it-or-leave-it type of company among financial market traders. Judging by the price trajectory of ...

Chatham-based Tonix Pharmaceuticals Holding Corp. and its wholly owned subsidiary Tonix Medicines Inc. announced June 26 that they entered into an agreement to acquire two fast-acting migraine ...

CHATHAM, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced an agreement ...

Phase 3 RESILIENT study of Tonmya met its primary endpoint of daily pain reduction (p=0.00005) and achieved statistically significant improvement ...